Evolus Capital Expenditures vs Stock Based Compensation Analysis

EOLS Stock

USD 14.74 0.30 1.99%

Evolus financial indicator trend analysis is much more than just examining Evolus Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolus Inc is a good investment. Please check the relationship between Evolus Capital Expenditures and its Stock Based Compensation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Capital Expenditures vs Stock Based Compensation

Capital Expenditures vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolus Inc Capital Expenditures account and Stock Based Compensation. At this time, the significance of the direction appears to have strong relationship.

The correlation between Evolus' Capital Expenditures and Stock Based Compensation is 0.63. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Evolus Inc, assuming nothing else is changed. The correlation between historical values of Evolus' Capital Expenditures and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Evolus Inc are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Capital Expenditures i.e., Evolus' Capital Expenditures and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by Evolus Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Evolus operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most indicators from Evolus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Evolus' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 212.5 K in 2025, whereas Enterprise Value Over EBITDA is likely to drop (14.99) in 2025.

Evolus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Non Currrent Assets Other	Capital Surpluse
Total Assets		0.51	0.7	0.11	-0.7	0.73	0.3	-0.33	-0.79	0.78	0.93	0.05	-0.28	0.74	0.65	0.87	0.67	0.61	0.79	-0.94	0.56	1.0	-0.32	-0.47	-0.93	0.87
Short Long Term Debt Total	0.51		0.43	0.74	-0.25	0.02	-0.55	0.63	-0.45	0.37	0.19	-0.05	-0.25	0.45	0.34	0.39	0.21	0.36	0.87	-0.59	0.84	0.5	0.5	-0.35	-0.62	0.54
Other Current Liab	0.7	0.43		0.37	-0.7	0.51	-0.16	-0.22	-0.73	0.87	0.71	0.01	-0.17	0.61	0.44	0.64	0.81	0.63	0.79	-0.64	0.23	0.71	-0.19	-0.4	-0.62	0.62
Total Current Liabilities	0.11	0.74	0.37		-0.32	-0.21	-0.85	0.66	-0.01	0.17	-0.08	0.14	0.06	-0.06	-0.16	-0.17	0.05	-0.04	0.58	-0.21	0.63	0.11	0.83	0.1	-0.24	0.05
Total Stockholder Equity	-0.7	-0.25	-0.7	-0.32		-0.54	-0.12	0.44	0.32	-0.58	-0.8	-0.41	-0.14	-0.23	-0.09	-0.38	-0.69	-0.16	-0.53	0.54	-0.28	-0.71	0.04	-0.09	0.53	-0.38
Other Liab	0.73	0.02	0.51	-0.21	-0.54		0.46	-0.64	-0.5	0.58	0.84	0.06	-0.2	0.4	0.31	0.68	0.34	0.3	0.4	-0.74	0.21	0.73	-0.52	-0.21	-0.72	0.56
Net Tangible Assets	0.3	-0.55	-0.16	-0.85	-0.12	0.46		-0.82	-0.15	0.04	0.48	0.05	-0.01	0.21	0.29	0.36	0.2	0.11	-0.33	-0.16	-0.31	0.3	-0.79	-0.09	-0.12	0.22
Net Debt	-0.33	0.63	-0.22	0.66	0.44	-0.64	-0.82		0.17	-0.3	-0.63	-0.17	-0.12	-0.15	-0.12	-0.34	-0.41	-0.1	0.22	0.17	0.45	-0.34	0.78	-0.04	0.13	-0.16
Retained Earnings	-0.79	-0.45	-0.73	-0.01	0.32	-0.5	-0.15	0.17		-0.81	-0.68	0.35	0.47	-0.94	-0.9	-0.89	-0.69	-0.94	-0.75	0.79	-0.36	-0.79	0.47	0.83	0.78	-0.92
Accounts Payable	0.78	0.37	0.87	0.17	-0.58	0.58	0.04	-0.3	-0.81		0.74	0.06	-0.19	0.7	0.56	0.74	0.65	0.66	0.72	-0.73	0.28	0.78	-0.35	-0.44	-0.71	0.72
Cash	0.93	0.19	0.71	-0.08	-0.8	0.84	0.48	-0.63	-0.68	0.74		0.11	-0.19	0.6	0.52	0.79	0.73	0.52	0.58	-0.81	0.28	0.93	-0.5	-0.33	-0.79	0.72
Non Current Assets Total	0.05	-0.05	0.01	0.14	-0.41	0.06	0.05	-0.17	0.35	0.06	0.11		0.83	-0.32	-0.58	-0.12	-0.06	-0.6	-0.07	0.05	-0.05	0.06	0.22	0.78	0.06	-0.23
Good Will	-0.28	-0.25	-0.17	0.06	-0.14	-0.2	-0.01	-0.12	0.47	-0.19	-0.19	0.83		-0.34	-0.61	-0.33	-0.16	-0.61	-0.3	0.32	-0.24	-0.25	0.27	0.73	0.32	-0.34
Common Stock Shares Outstanding	0.74	0.45	0.61	-0.06	-0.23	0.4	0.21	-0.15	-0.94	0.7	0.6	-0.32	-0.34		0.9	0.89	0.64	0.9	0.69	-0.73	0.36	0.75	-0.44	-0.83	-0.72	0.95
Short Term Investments	0.65	0.34	0.44	-0.16	-0.09	0.31	0.29	-0.12	-0.9	0.56	0.52	-0.58	-0.61	0.9		0.76	0.56	0.95	0.54	-0.66	0.35	0.65	-0.49	-0.94	-0.65	0.87
Non Current Liabilities Total	0.87	0.39	0.64	-0.17	-0.38	0.68	0.36	-0.34	-0.89	0.74	0.79	-0.12	-0.33	0.89	0.76		0.63	0.74	0.7	-0.81	0.31	0.86	-0.57	-0.65	-0.79	0.9
Other Current Assets	0.67	0.21	0.81	0.05	-0.69	0.34	0.2	-0.41	-0.69	0.65	0.73	-0.06	-0.16	0.64	0.56	0.63		0.68	0.55	-0.47	0.02	0.68	-0.41	-0.46	-0.44	0.59
Other Stockholder Equity	0.61	0.36	0.63	-0.04	-0.16	0.3	0.11	-0.1	-0.94	0.66	0.52	-0.6	-0.61	0.9	0.95	0.74	0.68		0.61	-0.61	0.25	0.61	-0.47	-0.94	-0.59	0.82
Total Liab	0.79	0.87	0.79	0.58	-0.53	0.4	-0.33	0.22	-0.75	0.72	0.58	-0.07	-0.3	0.69	0.54	0.7	0.55	0.61		-0.82	0.72	0.78	0.13	-0.51	-0.83	0.78
Deferred Long Term Liab	-0.94	-0.59	-0.64	-0.21	0.54	-0.74	-0.16	0.17	0.79	-0.73	-0.81	0.05	0.32	-0.73	-0.66	-0.81	-0.47	-0.61	-0.82		-0.72	-0.94	0.19	0.51	1.0	-0.9
Short Long Term Debt	0.56	0.84	0.23	0.63	-0.28	0.21	-0.31	0.45	-0.36	0.28	0.28	-0.05	-0.24	0.36	0.35	0.31	0.02	0.25	0.72	-0.72		0.56	0.49	-0.28	-0.74	0.57
Total Current Assets	1.0	0.5	0.71	0.11	-0.71	0.73	0.3	-0.34	-0.79	0.78	0.93	0.06	-0.25	0.75	0.65	0.86	0.68	0.61	0.78	-0.94	0.56		-0.32	-0.46	-0.93	0.88
Short Term Debt	-0.32	0.5	-0.19	0.83	0.04	-0.52	-0.79	0.78	0.47	-0.35	-0.5	0.22	0.27	-0.44	-0.49	-0.57	-0.41	-0.47	0.13	0.19	0.49	-0.32		0.41	0.15	-0.33
Intangible Assets	-0.47	-0.35	-0.4	0.1	-0.09	-0.21	-0.09	-0.04	0.83	-0.44	-0.33	0.78	0.73	-0.83	-0.94	-0.65	-0.46	-0.94	-0.51	0.51	-0.28	-0.46	0.41		0.51	-0.75
Non Currrent Assets Other	-0.93	-0.62	-0.62	-0.24	0.53	-0.72	-0.12	0.13	0.78	-0.71	-0.79	0.06	0.32	-0.72	-0.65	-0.79	-0.44	-0.59	-0.83	1.0	-0.74	-0.93	0.15	0.51		-0.89
Capital Surpluse	0.87	0.54	0.62	0.05	-0.38	0.56	0.22	-0.16	-0.92	0.72	0.72	-0.23	-0.34	0.95	0.87	0.9	0.59	0.82	0.78	-0.9	0.57	0.88	-0.33	-0.75	-0.89

Click cells to compare fundamentals

Evolus Account Relationship Matchups

Evolus fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	209.1M	257.5M	178.0M	189.0M	217.3M	190.3M
Short Long Term Debt Total	138.3M	74.7M	73.2M	126.5M	145.5M	103.1M
Other Current Liab	95.0M	49.0M	34.9M	31.6M	36.4M	28.7M
Total Current Liabilities	180.2M	57.7M	46.5M	48.3M	43.5M	61.0M
Total Stockholder Equity	(376.1M)	(422.9M)	18.5M	(20.7M)	(18.6M)	(19.6M)
Other Liab	59.1M	58.1M	44.5M	39.9M	45.9M	46.9M
Net Tangible Assets	(1.4M)	(149.5M)	10.0M	(51.3M)	(59.0M)	(62.0M)
Net Debt	35.8M	(71.5M)	19.3M	63.7M	57.3M	60.2M
Retained Earnings	(376.1M)	(422.9M)	(497.3M)	(559.0M)	(503.1M)	(477.9M)
Accounts Payable	9.6M	6.1M	8.9M	4.3M	4.9M	4.9M
Cash	102.6M	146.3M	53.9M	62.8M	72.3M	70.0M
Non Current Assets Total	81.5M	78.7M	77.2M	76.6M	68.9M	63.4M
Common Stock Shares Outstanding	33.7M	49.8M	56.1M	56.9M	65.5M	37.9M
Liabilities And Stockholders Equity	(94.0M)	(247.3M)	178.0M	189.0M	170.1M	178.6M
Non Current Liabilities Total	101.8M	117.9M	113.0M	161.4M	185.6M	94.2M
Other Current Assets	11.8M	16.1M	5.6M	8.1M	9.3M	6.4M
Other Stockholder Equity	303.1M	504.8M	516.1M	538.7M	619.5M	650.5M
Total Liab	282.0M	175.6M	159.5M	209.7M	241.1M	178.1M
Total Current Assets	127.6M	178.8M	100.8M	112.4M	129.3M	103.1M
Short Term Debt	75.6M	2.5M	2.6M	1.4M	1.2M	1.2M
Intangible Assets	55.3M	50.6M	48.6M	47.1M	42.4M	43.2M
Non Currrent Assets Other	240K	2.8M	2.8M	409K	368.1K	349.7K
Other Assets	3.7M	32.5M	2.8M	1.0	1.15	1.09
Net Receivables	9.7M	14.7M	22.4M	30.5M	27.5M	21.4M
Net Invested Capital	61M	153.1M	90.4M	99.7M	89.7M	92.8M
Net Working Capital	(52.6M)	121.1M	54.3M	64.1M	73.7M	41.5M
Long Term Debt	40.5M	71.2M	71.9M	120.4M	138.4M	75.6M
Cash And Short Term Investments	107.6M	146.3M	53.9M	62.8M	56.6M	79.1M
Property Plant And Equipment Net	4.7M	4.1M	4.6M	7.9M	9.0M	5.8M
Capital Lease Obligations	4.4M	3.5M	2.5M	6.2M	7.1M	4.8M
Inventory	3.4M	1.8M	18.9M	11.0M	12.6M	9.1M
Property Plant And Equipment Gross	4.7M	4.1M	4.6M	7.9M	9.0M	5.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC